Literature DB >> 7791761

Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.

L Nagy1, V A Thomázy, G L Shipley, L Fésüs, W Lamph, R A Heyman, R A Chandraratna, P J Davies.   

Abstract

Retinoids induce myeloblastic leukemia (HL-60) cells to differentiate into granulocytes, which subsequently die by apoptosis. Retinoid action is mediated through at least two classes of nuclear receptors: retinoic acid receptors, which bind both all-trans retinoic acid and 9-cis retinoic acid, and retinoid X receptors, which bind only 9-cis retinoic acid. Using receptor-selective synthetic retinoids and HL-60 cell sublines with different retinoid responsiveness, we have investigated the contribution that each class of receptors makes to the processes of cellular differentiation and death. Our results demonstrate that ligand activation of retinoic acid receptors is sufficient to induce differentiation, whereas ligand activation of retinoid X receptors is essential for the induction of apoptosis in HL-60 cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791761      PMCID: PMC230591          DOI: 10.1128/MCB.15.7.3540

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

Review 1.  Apoptosis: mechanisms and roles in pathology.

Authors:  M J Arends; A H Wyllie
Journal:  Int Rev Exp Pathol       Date:  1991

Review 2.  Apoptosis: molecular mechanisms in programmed cell death.

Authors:  L Fesus; P J Davies; M Piacentini
Journal:  Eur J Cell Biol       Date:  1991-12       Impact factor: 4.492

3.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR.

Authors:  D J Mangelsdorf; K Umesono; S A Kliewer; U Borgmeyer; E S Ong; R M Evans
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

4.  Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.

Authors:  C Delescluse; M T Cavey; B Martin; B A Bernard; U Reichert; J Maignan; M Darmon; B Shroot
Journal:  Mol Pharmacol       Date:  1991-10       Impact factor: 4.436

5.  bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

Authors:  D Delia; A Aiello; D Soligo; E Fontanella; C Melani; F Pezzella; M A Pierotti; G Della Porta
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

6.  Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes.

Authors:  J R Park; K Robertson; D D Hickstein; S Tsai; D M Hockenbery; S J Collins
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

7.  Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis.

Authors:  T G Cotter; S V Lennon; J M Glynn; D R Green
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

8.  9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.

Authors:  A A Levin; L J Sturzenbecker; S Kazmer; T Bosakowski; C Huselton; G Allenby; J Speck; C Kratzeisen; M Rosenberger; A Lovey
Journal:  Nature       Date:  1992-01-23       Impact factor: 49.962

9.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  Novel heteroarotinoids: synthesis and biological activity.

Authors:  L W Spruce; J B Gale; K D Berlin; A K Verma; T R Breitman; X H Ji; D van der Helm
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

View more
  31 in total

1.  Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

Authors:  Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; Seiji Adachi; Nobuhiro Kanemura; Senji Kasahara; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-31       Impact factor: 4.553

2.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Authors:  Wenli Liu; Hyun Woo Lee; Yueqin Liu; Ruihong Wang; Griffin P Rodgers
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

3.  Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.

Authors:  Q Wu; M I Dawson; Y Zheng; P D Hobbs; A Agadir; L Jong; Y Li; R Liu; B Lin; X K Zhang
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

4.  Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs.

Authors:  G Xu; M Redard; G Gabbiani; P Neuville
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 5.  Transglutaminase induction by various cell death and apoptosis pathways.

Authors:  L Fesus; A Madi; Z Balajthy; Z Nemes; Z Szondy
Journal:  Experientia       Date:  1996-10-31

6.  Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.

Authors:  Z Szondy; U Reichert; J M Bernardon; S Michel; R Tóth; E Karászi; L Fésüs
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

7.  All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.

Authors:  H Y Lee; D F Dohi; Y H Kim; G L Walsh; U Consoli; M Andreeff; M I Dawson; W K Hong; J M Kurie
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

8.  Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies.

Authors:  M H Koken; A Reid; F Quignon; M K Chelbi-Alix; J M Davies; J H Kabarowski; J Zhu; S Dong; S Chen; Z Chen; C C Tan; J Licht; S Waxman; H de Thé; A Zelent
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

9.  Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes.

Authors:  Yang-Yi Fan; Thomas E Spencer; Naisyin Wang; Mary P Moyer; Robert S Chapkin
Journal:  Carcinogenesis       Date:  2003-07-04       Impact factor: 4.944

Review 10.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.